A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with international collaborators, published in the journal Signal Transduction and Targeted Therapy.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗